The effect of glucagon-like peptide 1 on cardiovascular risk

Medicin og biovidenskab

• Atherosclerosis 13%
• Blood Pressure 10%
• Body Weight 12%
• Cardiovascular Diseases 24%
• Dipeptidyl-Peptidase IV Inhibitors 22%
• Enzymes 9%
• Glucagon-Like Peptide 1 100%
• Glucagon-Like Peptide-1 Receptor 44%
• Glucose 32%
• Hormones 12%
• Incretins 44%
• Insulin Secretion 16%
• Left Ventricular Function 16%
• Lipid Metabolism 16%
• Nutrients 14%
• Reperfusion Injury 16%
• Therapeutics 11%
• Type 2 Diabetes Mellitus 25%